Andrew Booth - 07 Dec 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Chief Financial Officer
Signature: /s/ Tryn Stimart, attorney in fact
Issuer symbol: ABCL
Transactions as of: 07 Dec 2021
Transactions value $: $0
Form type: 4
Filing time: 09 Dec 2021, 16:58:32 UTC
Previous filing: 15 Nov 2021
Next filing: 10 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ABCL	Common Shares						53.5K	07 Dec 2021	Direct
holding	ABCL	Common Shares						131K	07 Dec 2021	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABCL	Share Option (right to buy)	Award	$0	+406K	+7.41%	$0.00	5.88M	07 Dec 2021	Common Shares	406K	$14.55	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date